{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:18:49Z","timestamp":1793776729886,"version":"4.6.1"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Swedish State Support for Clinical Research","award":["#AFLGBG-71320"],"award-info":[{"award-number":["#AFLGBG-71320"]}]},{"DOI":"10.13039\/100010146","name":"Alzheimer Forschung Initiative","doi-asserted-by":"publisher","award":["19084"],"award-info":[{"award-number":["19084"]}],"id":[{"id":"10.13039\/100010146","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Kl 819\/9-1"],"award-info":[{"award-number":["Kl 819\/9-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BioComp"},{"name":"TU Nachwuchsring"},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["#2018-02532"],"award-info":[{"award-number":["#2018-02532"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Union's Horizon Europe research and innovation programme","award":["No 101053962"],"award-info":[{"award-number":["No 101053962"]}]},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","award":["#201809-2016862"],"award-info":[{"award-number":["#201809-2016862"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AD Strategic Fund and the Alzheimer's Association","award":["#ADSF-21-831376-C"],"award-info":[{"award-number":["#ADSF-21-831376-C"]}]},{"name":"AD Strategic Fund and the Alzheimer's Association","award":["#ADSF-21-831381-C"],"award-info":[{"award-number":["#ADSF-21-831381-C"]}]},{"name":"AD Strategic Fund and the Alzheimer's Association","award":["#ADSF-21-831377-C"],"award-info":[{"award-number":["#ADSF-21-831377-C"]}]},{"name":"the Bluefield Project, the Olav Thon Foundation, the Erling-Persson Family Foundation, Stiftelsen f\u00f6r Gamla Tj\u00e4narinnor, Hj\u00e4rnfonden, Sweden","award":["#F02022-0270"],"award-info":[{"award-number":["#F02022-0270"]}]},{"DOI":"10.13039\/100018694","name":"HORIZON EUROPE Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["No 860197 (MIRIADE)"],"award-info":[{"award-number":["No 860197 (MIRIADE)"]}],"id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["UKDRI-1003"],"award-info":[{"award-number":["UKDRI-1003"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Max Planck Institute for Multidisciplinary Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The amyloid precursor protein (APP) is a key player in Alzheimer`s disease (AD) and the precursor of the A\u03b2 peptide, which is generated by consecutive cleavages of \u03b2- and \u03b3-secretases. Familial Alzheimer\u2019s disease (FAD) describes a hereditary subgroup of AD that represents a low percentage of AD cases with an early onset of the disease. Different APP FAD mutations are thought to have qualitatively different effects on its proteolytic conversion. However, few studies have explored the pathogenic and putative physiological differences in more detail. Here, we compared different FAD mutations, located at the \u03b2- (Swedish), \u03b1- (Flemish, Arctic, Iowa) or \u03b3-secretase (Iberian) cleavage sites. We examined heterologous expression of APP WT and FAD mutants in non-neuronal cells and their impact on presynaptic differentiation in contacting axons of co-cultured neurons. To decipher the underlying molecular mechanism, we tested the subcellular localization, the endocytosis rate and the proteolytic processing in detail by immunoprecipitation\u2013mass spectrometry. Interestingly, we found that only the Iberian mutation showed altered synaptogenic function. Furthermore, the APP Iowa mutant shows significantly decreased \u03b1-secretase processing which is in line with our results that APP carrying the Iowa mutation was significantly increased in early endosomes. However, most interestingly, immunoprecipitation\u2013mass spectrometry analysis revealed that the amino acid substitutions of APP FAD mutants have a decisive impact on their processing reflected in altered A\u03b2 profiles. Importantly, N-terminally truncated A\u03b2 peptides starting at position 5 were detected preferentially for APP Flemish, Arctic, and Iowa mutants containing amino acid substitutions around the \u03b1-secretase cleavage site. The strongest change in the ratio of A\u03b240\/A\u03b242 was observed for the Iberian mutation while APP Swedish showed a substantial increase in A\u03b21\u201317 peptides. Together, our data indicate that familial AD mutations located at the \u03b1-, \u03b2-, and \u03b3-secretase cleavage sites show considerable differences in the underlying pathogenic mechanisms.<\/jats:p>","DOI":"10.1186\/s40478-023-01577-y","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T03:38:37Z","timestamp":1685590717000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Differential effects of familial Alzheimer\u2019s disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity"],"prefix":"10.1186","volume":"11","author":[{"given":"Sandra","family":"Schilling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Heesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Helbig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Bertgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward H.","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Brinkmalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Eggert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,1]]},"reference":[{"key":"1577_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/bs.pmbts.2019.07.002","volume":"168","author":"MS Wolfe","year":"2019","unstructured":"Wolfe MS (2019) In search of pathogenic amyloid beta-peptide in familial Alzheimer\u2019s disease. Prog Mol Biol Transl Sci 168:71\u201378","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"12","key":"1577_CR2","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/S1474-4422(09)70298-4","volume":"8","author":"JF Dartigues","year":"2009","unstructured":"Dartigues JF (2009) Alzheimer\u2019s disease: a global challenge for the 21st century. Lancet Neurol 8(12):1082\u20131083","journal-title":"Lancet Neurol"},{"issue":"7","key":"1577_CR3","doi-asserted-by":"publisher","first-page":"5809","DOI":"10.1007\/s12035-017-0806-x","volume":"55","author":"S Eggert","year":"2018","unstructured":"Eggert S et al (2018) Trafficking in Alzheimer\u2019s Disease: modulation of APP transport and processing by the transmembrane proteins LRP1, SorLA, SorCS1c, Sortilin, and Calsyntenin. Mol Neurobiol 55(7):5809\u20135829","journal-title":"Mol Neurobiol"},{"key":"1577_CR4","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201899456","author":"SF Lichtenthaler","year":"2018","unstructured":"Lichtenthaler SF, Lemberg MK, Fluhrer R (2018) Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments. EMBO J. https:\/\/doi.org\/10.15252\/embj.201899456","journal-title":"EMBO J"},{"issue":"1","key":"1577_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1515\/hsz-2021-0330","volume":"403","author":"S Eggert","year":"2022","unstructured":"Eggert S et al (2022) Brothers in arms: proBDNF\/BDNF and sAPPalpha\/Abeta-signaling and their common interplay with ADAM10, TrkB, p75NTR, sortilin, and sorLA in the progression of Alzheimer\u2019s disease. Biol Chem 403(1):43\u201371","journal-title":"Biol Chem"},{"key":"1577_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.conb.2020.01.011","volume":"61","author":"J Trambauer","year":"2020","unstructured":"Trambauer J, Fukumori A, Steiner H (2020) Pathogenic Abeta generation in familial Alzheimer\u2019s disease: novel mechanistic insights and therapeutic implications. Curr Opin Neurobiol 61:73\u201381","journal-title":"Curr Opin Neurobiol"},{"issue":"8","key":"1577_CR7","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1021\/bi015794o","volume":"41","author":"A Weidemann","year":"2002","unstructured":"Weidemann A et al (2002) A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing. Biochemistry 41(8):2825\u20132835","journal-title":"Biochemistry"},{"issue":"38","key":"1577_CR8","doi-asserted-by":"publisher","first-page":"35235","DOI":"10.1074\/jbc.C100357200","volume":"276","author":"Y Gu","year":"2001","unstructured":"Gu Y et al (2001) Distinct intramembrane cleavage of the beta-amyloid precursor protein family resembling gamma-secretase-like cleavage of Notch. J Biol Chem 276(38):35235\u201335238","journal-title":"J Biol Chem"},{"issue":"11","key":"1577_CR9","doi-asserted-by":"publisher","first-page":"292","DOI":"10.15698\/cst2018.11.162","volume":"2","author":"H Steiner","year":"2018","unstructured":"Steiner H et al (2018) Making the final cut: pathogenic amyloid-beta peptide generation by gamma-secretase. Cell Stress 2(11):292\u2013310","journal-title":"Cell Stress"},{"issue":"2","key":"1577_CR10","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1523\/JNEUROSCI.1575-04.2005","volume":"25","author":"Y Qi-Takahara","year":"2005","unstructured":"Qi-Takahara Y et al (2005) Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase. J Neurosci 25(2):436\u2013445","journal-title":"J Neurosci"},{"issue":"12","key":"1577_CR11","doi-asserted-by":"publisher","first-page":"7977","DOI":"10.1074\/jbc.272.12.7977","volume":"272","author":"W Xia","year":"1997","unstructured":"Xia W et al (1997) Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J Biol Chem 272(12):7977\u20137982","journal-title":"J Biol Chem"},{"issue":"6577","key":"1577_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1126\/science.abm7285","volume":"375","author":"Y Yang","year":"2022","unstructured":"Yang Y et al (2022) Cryo-EM structures of amyloid-beta 42 filaments from human brains. Science 375(6577):167\u2013172","journal-title":"Science"},{"issue":"2","key":"1577_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/alzrt107","volume":"4","author":"S Weggen","year":"2012","unstructured":"Weggen S, Beher D (2012) Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther 4(2):9","journal-title":"Alzheimer's Res Ther"},{"issue":"3","key":"1577_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nm0397-328","volume":"3","author":"A Weidemann","year":"1997","unstructured":"Weidemann A et al (1997) Formation of stable complexes between two Alzheimer\u2019s disease gene products: presenilin-2 and beta-amyloid precursor protein. Nat Med 3(3):328\u2013332","journal-title":"Nat Med"},{"issue":"6727","key":"1577_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/19077","volume":"398","author":"MS Wolfe","year":"1999","unstructured":"Wolfe MS et al (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398(6727):513\u2013517","journal-title":"Nature"},{"issue":"6405","key":"1577_CR16","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/360672a0","volume":"360","author":"M Citron","year":"1992","unstructured":"Citron M et al (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer\u2019s disease increases beta-protein production. Nature 360(6405):672\u2013674","journal-title":"Nature"},{"issue":"5","key":"1577_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng0892-345","volume":"1","author":"M Mullan","year":"1992","unstructured":"Mullan M et al (1992) A pathogenic mutation for probable Alzheimer\u2019s disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet 1(5):345\u2013347","journal-title":"Nat Genet"},{"issue":"9","key":"1577_CR18","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nn0901-887","volume":"4","author":"C Nilsberth","year":"2001","unstructured":"Nilsberth C et al (2001) The \u201cArctic\u201d APP mutation (E693G) causes Alzheimer\u2019s disease by enhanced Abeta protofibril formation. Nat Neurosci 4(9):887\u2013893","journal-title":"Nat Neurosci"},{"issue":"6","key":"1577_CR19","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ana.1009","volume":"49","author":"TJ Grabowski","year":"2001","unstructured":"Grabowski TJ et al (2001) Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 49(6):697\u2013705","journal-title":"Ann Neurol"},{"issue":"3","key":"1577_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/ng0692-218","volume":"1","author":"L Hendriks","year":"1992","unstructured":"Hendriks L et al (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet 1(3):218\u2013221","journal-title":"Nat Genet"},{"issue":"6","key":"1577_CR21","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1529\/biophysj.107.121467","volume":"94","author":"NL Fawzi","year":"2008","unstructured":"Fawzi NL et al (2008) Protofibril assemblies of the arctic, Dutch, and Flemish mutants of the Alzheimer\u2019s Abeta1-40 peptide. Biophys J 94(6):2007\u20132016","journal-title":"Biophys J"},{"issue":"1","key":"1577_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jmb.2004.03.028","volume":"339","author":"A Paivio","year":"2004","unstructured":"Paivio A et al (2004) Unique physicochemical profile of beta-amyloid peptide variant Abeta1-40E22G protofibrils: conceivable neuropathogen in arctic mutant carriers. J Mol Biol 339(1):145\u2013159","journal-title":"J Mol Biol"},{"issue":"2","key":"1577_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jsb.2008.07.010","volume":"164","author":"S Rodziewicz-Motowidlo","year":"2008","unstructured":"Rodziewicz-Motowidlo S et al (2008) The Arctic mutation alters helix length and type in the 11\u201328 beta-amyloid peptide monomer-CD, NMR and MD studies in an SDS micelle. J Struct Biol 164(2):199\u2013209","journal-title":"J Struct Biol"},{"issue":"35","key":"1577_CR24","doi-asserted-by":"publisher","first-page":"32860","DOI":"10.1074\/jbc.M104135200","volume":"276","author":"WE Van Nostrand","year":"2001","unstructured":"Van Nostrand WE et al (2001) Pathogenic effects of D23N Iowa mutant amyloid beta -protein. J Biol Chem 276(35):32860\u201332866","journal-title":"J Biol Chem"},{"issue":"Pt 10","key":"1577_CR25","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1093\/brain\/123.10.2130","volume":"123","author":"G Roks","year":"2000","unstructured":"Roks G et al (2000) Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692). Brain 123(Pt 10):2130\u20132140","journal-title":"Brain"},{"issue":"4","key":"1577_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/archneur.65.4.499","volume":"65","author":"H Basun","year":"2008","unstructured":"Basun H et al (2008) Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease. Arch Neurol 65(4):499\u2013505","journal-title":"Arch Neurol"},{"issue":"4","key":"1577_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1006\/nbdi.1998.0202","volume":"5","author":"C De Jonghe","year":"1998","unstructured":"De Jonghe C et al (1998) Flemish and Dutch mutations in amyloid beta precursor protein have different effects on amyloid beta secretion. Neurobiol Dis 5(4):281\u2013286","journal-title":"Neurobiol Dis"},{"issue":"6","key":"1577_CR28","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1073\/pnas.96.6.3053","volume":"96","author":"SF Lichtenthaler","year":"1999","unstructured":"Lichtenthaler SF et al (1999) Mechanism of the cleavage specificity of Alzheimer\u2019s disease gamma-secretase identified by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein. Proc Natl Acad Sci U S A 96(6):3053\u20133058","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1577_CR29","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.neurobiolaging.2008.06.012","volume":"31","author":"RJ Guerreiro","year":"2010","unstructured":"Guerreiro RJ et al (2010) Genetic screening of Alzheimer\u2019s disease genes in Iberian and African samples yields novel mutations in presenilins and APP. Neurobiol Aging 31(5):725\u2013731","journal-title":"Neurobiol Aging"},{"issue":"28","key":"1577_CR30","doi-asserted-by":"publisher","first-page":"21636","DOI":"10.1074\/jbc.M109.088005","volume":"285","author":"LM Munter","year":"2010","unstructured":"Munter LM et al (2010) Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif. J Biol Chem 285(28):21636\u201321643","journal-title":"J Biol Chem"},{"issue":"26","key":"1577_CR31","doi-asserted-by":"publisher","first-page":"17741","DOI":"10.1016\/S0021-9258(17)32503-6","volume":"269","author":"C Haass","year":"1994","unstructured":"Haass C et al (1994) Mutations associated with a locus for familial Alzheimer\u2019s disease result in alternative processing of amyloid beta-protein precursor. J Biol Chem 269(26):17741\u201317748","journal-title":"J Biol Chem"},{"issue":"5","key":"1577_CR32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrn.2017.29","volume":"18","author":"UC Muller","year":"2017","unstructured":"Muller UC, Deller T, Korte M (2017) Not just amyloid: physiological functions of the amyloid precursor protein family. Nat Rev Neurosci 18(5):281\u2013298","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"1577_CR33","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.neuron.2019.01.058","volume":"101","author":"C Haass","year":"2019","unstructured":"Haass C, Willem M (2019) Secreted APP modulates synaptic activity: A novel target for therapeutic intervention? Neuron 101(4):557\u2013559","journal-title":"Neuron"},{"issue":"1","key":"1577_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00401-014-1368-x","volume":"129","author":"M Hick","year":"2015","unstructured":"Hick M et al (2015) Acute function of secreted amyloid precursor protein fragment APPsalpha in synaptic plasticity. Acta Neuropathol 129(1):21\u201337","journal-title":"Acta Neuropathol"},{"issue":"21","key":"1577_CR35","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1523\/JNEUROSCI.1875-16.2017","volume":"37","author":"S Schilling","year":"2017","unstructured":"Schilling S et al (2017) APLP1 Is a synaptic cell adhesion molecule, supporting maintenance of dendritic spines and basal synaptic transmission. J Neurosci 37(21):5345\u20135365","journal-title":"J Neurosci"},{"key":"1577_CR36","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3389\/fncel.2014.00410","volume":"8","author":"R Stahl","year":"2014","unstructured":"Stahl R et al (2014) Shedding of APP limits its synaptogenic activity and cell adhesion properties. Front Cell Neurosci 8:410","journal-title":"Front Cell Neurosci"},{"issue":"20","key":"1577_CR37","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1038\/sj.emboj.7600824","volume":"24","author":"P Soba","year":"2005","unstructured":"Soba P et al (2005) Homo- and heterodimerization of APP family members promotes intercellular adhesion. EMBO J 24(20):3624\u20133634","journal-title":"EMBO J"},{"issue":"2","key":"1577_CR38","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1006\/abio.1994.1112","volume":"217","author":"H Schagger","year":"1994","unstructured":"Schagger H, Cramer WA, von Jagow G (1994) Analysis of molecular masses and oligomeric states of protein complexes by blue native electrophoresis and isolation of membrane protein complexes by two-dimensional native electrophoresis. Anal Biochem 217(2):220\u2013230","journal-title":"Anal Biochem"},{"issue":"42","key":"1577_CR39","doi-asserted-by":"publisher","first-page":"28943","DOI":"10.1074\/jbc.M109.038646","volume":"284","author":"S Eggert","year":"2009","unstructured":"Eggert S et al (2009) Induced dimerization of the amyloid precursor protein leads to decreased amyloid-beta protein production. J Biol Chem 284(42):28943\u201328952","journal-title":"J Biol Chem"},{"issue":"6","key":"1577_CR40","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0092-8674(00)80877-6","volume":"101","author":"P Scheiffele","year":"2000","unstructured":"Scheiffele P et al (2000) Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 101(6):657\u2013669","journal-title":"Cell"},{"issue":"11","key":"1577_CR41","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1021\/pr0703627","volume":"6","author":"E Portelius","year":"2007","unstructured":"Portelius E et al (2007) Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry. J Proteome Res 6(11):4433\u20134439","journal-title":"J Proteome Res"},{"issue":"35","key":"1577_CR42","doi-asserted-by":"publisher","first-page":"10788","DOI":"10.1523\/JNEUROSCI.2132-09.2009","volume":"29","author":"Z Wang","year":"2009","unstructured":"Wang Z et al (2009) Presynaptic and postsynaptic interaction of the amyloid precursor protein promotes peripheral and central synaptogenesis. J Neurosci Off J Soc Neurosci 29(35):10788\u201310801","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"2","key":"1577_CR43","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1006\/nbdi.2002.0529","volume":"11","author":"S Kumar-Singh","year":"2002","unstructured":"Kumar-Singh S et al (2002) In vitro studies of Flemish, Dutch, and wild-type beta-amyloid provide evidence for two-staged neurotoxicity. Neurobiol Dis 11(2):330\u2013340","journal-title":"Neurobiol Dis"},{"issue":"15","key":"1577_CR44","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1097\/00001756-200210280-00005","volume":"13","author":"C Stenh","year":"2002","unstructured":"Stenh C et al (2002) The Arctic mutation interferes with processing of the amyloid precursor protein. NeuroReport 13(15):1857\u20131860","journal-title":"NeuroReport"},{"key":"1577_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102517","volume":"46","author":"D Kobylarek","year":"2020","unstructured":"Kobylarek D et al (2020) A case report: Co-occurrence of cerebral amyloid angiopathy and multiple sclerosis. Mult Scler Relat Disord 46:102517","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"1577_CR46","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.conb.2010.08.016","volume":"21","author":"TJ Siddiqui","year":"2011","unstructured":"Siddiqui TJ, Craig AM (2011) Synaptic organizing complexes. Curr Opin Neurobiol 21(1):132\u2013143","journal-title":"Curr Opin Neurobiol"},{"issue":"24","key":"1577_CR47","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1007\/s00018-020-03467-1","volume":"77","author":"S Eggert","year":"2020","unstructured":"Eggert S et al (2020) The Rab5 activator RME-6 is required for amyloid precursor protein endocytosis depending on the YTSI motif. Cell Mol Life Sci 77(24):5223\u20135242","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"1577_CR48","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00018-017-2625-7","volume":"75","author":"S Eggert","year":"2018","unstructured":"Eggert S et al (2018) Dimerization leads to changes in APP (amyloid precursor protein) trafficking mediated by LRP1 and SorLA. Cell Mol Life Sci 75(2):301\u2013322","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"1577_CR49","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1074\/jbc.M116.755264","volume":"292","author":"A Hatami","year":"2017","unstructured":"Hatami A et al (2017) Familial Alzheimer\u2019s disease mutations within the amyloid precursor protein alter the aggregation and conformation of the amyloid-beta peptide. J Biol Chem 292(8):3172\u20133185","journal-title":"J Biol Chem"},{"issue":"2","key":"1577_CR50","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0002-9440(10)64207-1","volume":"161","author":"S Kumar-Singh","year":"2002","unstructured":"Kumar-Singh S et al (2002) Dense-core senile plaques in the Flemish variant of Alzheimer\u2019s disease are vasocentric. Am J Pathol 161(2):507\u2013520","journal-title":"Am J Pathol"},{"key":"1577_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/2051-5960-1-60","volume":"1","author":"H Kalimo","year":"2013","unstructured":"Kalimo H et al (2013) The Arctic AbetaPP mutation leads to Alzheimer\u2019s disease pathology with highly variable topographic deposition of differentially truncated Abeta. Acta Neuropathol Commun 1:60","journal-title":"Acta Neuropathol Commun"},{"key":"1577_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100281","volume":"296","author":"S Devkota","year":"2021","unstructured":"Devkota S, Williams TD, Wolfe MS (2021) Familial Alzheimer\u2019s disease mutations in amyloid protein precursor alter proteolysis by gamma-secretase to increase amyloid beta-peptides of >\/=45 residues. J Biol Chem 296:100281","journal-title":"J Biol Chem"},{"issue":"33","key":"1577_CR53","doi-asserted-by":"publisher","first-page":"11159","DOI":"10.1523\/JNEUROSCI.0180-14.2014","volume":"34","author":"F Baumkotter","year":"2014","unstructured":"Baumkotter F et al (2014) Amyloid precursor protein dimerization and synaptogenic function depend on copper binding to the growth factor-like domain. J Neurosci Off J Soc Neurosci 34(33):11159\u201311172","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"10","key":"1577_CR54","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H et al (2021) The amyloid-beta pathway in Alzheimer\u2019s disease. Mol Psychiatry 26(10):5481\u20135503","journal-title":"Mol Psychiatry"},{"issue":"2","key":"1577_CR55","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat Rev Mol Cell Biol 8(2):101\u2013112","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"1577_CR56","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1021\/cn300050d","volume":"3","author":"MM Gessel","year":"2012","unstructured":"Gessel MM et al (2012) Familial Alzheimer\u2019s disease mutations differentially alter amyloid beta-protein oligomerization. ACS Chem Neurosci 3(11):909\u2013918","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"1577_CR57","first-page":"15","volume":"2","author":"PP So","year":"2013","unstructured":"So PP et al (2013) Comparable dimerization found in wildtype and familial Alzheimer\u2019s disease amyloid precursor protein mutants. Am J Neurodegener Dis 2(1):15\u201328","journal-title":"Am J Neurodegener Dis"},{"issue":"12","key":"1577_CR58","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/nm1295-1291","volume":"1","author":"C Haass","year":"1995","unstructured":"Haass C et al (1995) The Swedish mutation causes early-onset Alzheimer\u2019s disease by beta-secretase cleavage within the secretory pathway. Nat Med 1(12):1291\u20131296","journal-title":"Nat Med"},{"issue":"5","key":"1577_CR59","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/alzrt211","volume":"5","author":"X Zhang","year":"2013","unstructured":"Zhang X, Song W (2013) The role of APP and BACE1 trafficking in APP processing and amyloid-beta generation. Alzheimers Res Ther 5(5):46","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"1577_CR60","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1111\/j.1471-4159.2009.06420.x","volume":"111","author":"S Jager","year":"2009","unstructured":"Jager S et al (2009) alpha-secretase mediated conversion of the amyloid precursor protein derived membrane stub C99 to C83 limits Abeta generation. J Neurochem 111(6):1369\u20131382","journal-title":"J Neurochem"},{"issue":"16","key":"1577_CR61","doi-asserted-by":"publisher","first-page":"9390","DOI":"10.1074\/jbc.271.16.9390","volume":"271","author":"G Thinakaran","year":"1996","unstructured":"Thinakaran G et al (1996) Metabolism of the \u201cSwedish\u201d amyloid precursor protein variant in neuro2a (N2a) cells. Evidence that cleavage at the \u201cbeta-secretase\u201d site occurs in the golgi apparatus. J Biol Chem 271(16):9390\u20139397","journal-title":"J Biol Chem"},{"issue":"3","key":"1577_CR62","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/bies.201400116","volume":"37","author":"G Joshi","year":"2015","unstructured":"Joshi G, Wang Y (2015) Golgi defects enhance APP amyloidogenic processing in Alzheimer\u2019s disease. BioEssays 37(3):240\u2013247","journal-title":"BioEssays"},{"issue":"2","key":"1577_CR63","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1073\/pnas.96.2.742","volume":"96","author":"JP Greenfield","year":"1999","unstructured":"Greenfield JP et al (1999) Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc Natl Acad Sci U S A 96(2):742\u2013747","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5440","key":"1577_CR64","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.286.5440.735","volume":"286","author":"R Vassar","year":"1999","unstructured":"Vassar R et al (1999) Beta-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286(5440):735\u2013741","journal-title":"Science"},{"issue":"26","key":"1577_CR65","doi-asserted-by":"publisher","first-page":"17386","DOI":"10.1016\/S0021-9258(17)32449-3","volume":"269","author":"EH Koo","year":"1994","unstructured":"Koo EH, Squazzo SL (1994) Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem 269(26):17386\u201317389","journal-title":"J Biol Chem"},{"issue":"6085","key":"1577_CR66","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1126\/science.1219988","volume":"336","author":"PJ Barrett","year":"2012","unstructured":"Barrett PJ et al (2012) The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol. Science 336(6085):1168\u20131171","journal-title":"Science"},{"issue":"5284","key":"1577_CR67","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K et al (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274(5284):99\u2013102","journal-title":"Science"},{"issue":"2","key":"1577_CR68","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/cne.21176","volume":"500","author":"H Dong","year":"2007","unstructured":"Dong H et al (2007) Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice. J Comp Neurol 500(2):311\u2013321","journal-title":"J Comp Neurol"},{"issue":"5489","key":"1577_CR69","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1126\/science.290.5489.150","volume":"290","author":"L Hong","year":"2000","unstructured":"Hong L et al (2000) Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. Science 290(5489):150\u2013153","journal-title":"Science"},{"issue":"20","key":"1577_CR70","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1021\/bi200081h","volume":"50","author":"A Barman","year":"2011","unstructured":"Barman A, Schurer S, Prabhakar R (2011) Computational modeling of substrate specificity and catalysis of the beta-secretase (BACE1) enzyme. Biochemistry 50(20):4337\u20134349","journal-title":"Biochemistry"},{"issue":"5","key":"1577_CR71","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1046\/j.1471-4159.2003.01597.x","volume":"84","author":"AG Tomasselli","year":"2003","unstructured":"Tomasselli AG et al (2003) Employing a superior BACE1 cleavage sequence to probe cellular APP processing. J Neurochem 84(5):1006\u20131017","journal-title":"J Neurochem"},{"issue":"3","key":"1577_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2021.119164","volume":"1869","author":"F Armbrust","year":"2022","unstructured":"Armbrust F et al (2022) The Swedish dilemma\u2014the almost exclusive use of APPswe-based mouse models impedes adequate evaluation of alternative beta-secretases. Biochim Biophys Acta Mol Cell Res 1869(3):119164","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"2","key":"1577_CR73","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.neuron.2019.07.010","volume":"104","author":"D Kwart","year":"2019","unstructured":"Kwart D et al (2019) A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP beta-CTFs, Not Abeta. Neuron 104(2):256-270 e5","journal-title":"Neuron"},{"issue":"6","key":"1577_CR74","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1111\/j.1471-4159.2006.04178.x","volume":"99","author":"K Nishitomi","year":"2006","unstructured":"Nishitomi K et al (2006) BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice. J Neurochem 99(6):1555\u20131563","journal-title":"J Neurochem"},{"issue":"10","key":"1577_CR75","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1515\/cclm-2014-1048","volume":"53","author":"P Bros","year":"2015","unstructured":"Bros P et al (2015) Quantitative detection of amyloid-beta peptides by mass spectrometry: state of the art and clinical applications. Clin Chem Lab Med 53(10):1483\u20131493","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"1577_CR76","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2217\/17520363.1.1.59","volume":"1","author":"U Andreasson","year":"2007","unstructured":"Andreasson U et al (2007) Aspects of beta-amyloid as a biomarker for Alzheimer\u2019s disease. Biomark Med 1(1):59\u201378","journal-title":"Biomark Med"},{"issue":"41","key":"1577_CR77","doi-asserted-by":"publisher","first-page":"13042","DOI":"10.1523\/JNEUROSCI.2362-09.2009","volume":"29","author":"M Takami","year":"2009","unstructured":"Takami M et al (2009) gamma-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment. J Neurosci 29(41):13042\u201313052","journal-title":"J Neurosci"},{"issue":"17","key":"1577_CR78","doi-asserted-by":"publisher","first-page":"9712","DOI":"10.1073\/pnas.160115697","volume":"97","author":"M Farzan","year":"2000","unstructured":"Farzan M et al (2000) BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. Proc Natl Acad Sci U S A 97(17):9712\u20139717","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4959","key":"1577_CR79","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science.2111583","volume":"248","author":"FS Esch","year":"1990","unstructured":"Esch FS et al (1990) Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248(4959):1122\u20131124","journal-title":"Science"},{"issue":"6","key":"1577_CR80","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1515\/bc.2011.054","volume":"392","author":"I Schechter","year":"2011","unstructured":"Schechter I, Ziv E (2011) Cathepsins S, B and L with aminopeptidases display beta-secretase activity associated with the pathogenesis of Alzheimer\u2019s disease. Biol Chem 392(6):555\u2013569","journal-title":"Biol Chem"},{"issue":"1","key":"1577_CR81","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0304-3940(93)90133-6","volume":"161","author":"C Schonlein","year":"1993","unstructured":"Schonlein C, Probst A, Huber G (1993) Characterization of proteases with the specificity to cleave at the secretase-site of beta-APP. Neurosci Lett 161(1):33\u201336","journal-title":"Neurosci Lett"},{"issue":"34","key":"1577_CR82","doi-asserted-by":"publisher","first-page":"24566","DOI":"10.1074\/jbc.M602440200","volume":"281","author":"P Yan","year":"2006","unstructured":"Yan P et al (2006) Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ. J Biol Chem 281(34):24566\u201324574","journal-title":"J Biol Chem"},{"issue":"24","key":"1577_CR83","doi-asserted-by":"publisher","first-page":"15078","DOI":"10.1074\/jbc.M114.610931","volume":"290","author":"M Hernandez-Guillamon","year":"2015","unstructured":"Hernandez-Guillamon M et al (2015) Sequential amyloid-beta degradation by the matrix metalloproteases MMP-2 and MMP-9. J Biol Chem 290(24):15078\u201315091","journal-title":"J Biol Chem"},{"issue":"4","key":"1577_CR84","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1021\/pr050475v","volume":"5","author":"E Portelius","year":"2006","unstructured":"Portelius E et al (2006) Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry. J Proteome Res 5(4):1010\u20131016","journal-title":"J Proteome Res"},{"issue":"6","key":"1577_CR85","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","volume":"40","author":"MA Leissring","year":"2003","unstructured":"Leissring MA et al (2003) Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40(6):1087\u20131093","journal-title":"Neuron"},{"issue":"2","key":"1577_CR86","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/72237","volume":"6","author":"N Iwata","year":"2000","unstructured":"Iwata N et al (2000) Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 6(2):143\u2013150","journal-title":"Nat Med"},{"issue":"4","key":"1577_CR87","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/0196-9781(95)00021-B","volume":"16","author":"S Howell","year":"1995","unstructured":"Howell S, Nalbantoglu J, Crine P (1995) Neutral endopeptidase can hydrolyze beta-amyloid(1\u201340) but shows no effect on beta-amyloid precursor protein metabolism. Peptides 16(4):647\u2013652","journal-title":"Peptides"},{"issue":"2","key":"1577_CR88","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.neuroscience.2006.08.027","volume":"143","author":"A Guntert","year":"2006","unstructured":"Guntert A, Dobeli H, Bohrmann B (2006) High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Neuroscience 143(2):461\u2013475","journal-title":"Neuroscience"},{"issue":"11","key":"1577_CR89","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1002\/j.1460-2075.1985.tb04000.x","volume":"4","author":"CL Masters","year":"1985","unstructured":"Masters CL et al (1985) Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer\u2019s disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J 4(11):2757\u20132763","journal-title":"EMBO J"},{"issue":"2","key":"1577_CR90","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1006\/bbrc.2000.3490","volume":"276","author":"Y Harigaya","year":"2000","unstructured":"Harigaya Y et al (2000) Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer\u2019s disease brain. Biochem Biophys Res Commun 276(2):422\u2013427","journal-title":"Biochem Biophys Res Commun"},{"key":"1577_CR91","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-016-0084-5","volume":"11","author":"C Schonherr","year":"2016","unstructured":"Schonherr C et al (2016) Generation of aggregation prone N-terminally truncated amyloid beta peptides by meprin beta depends on the sequence specificity at the cleavage site. Mol Neurodegener 11:19","journal-title":"Mol Neurodegener"},{"issue":"12","key":"1577_CR92","doi-asserted-by":"publisher","first-page":"7745","DOI":"10.1074\/jbc.M708362200","volume":"283","author":"VY Hook","year":"2008","unstructured":"Hook VY, Kindy M, Hook G (2008) Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. J Biol Chem 283(12):7745\u20137753","journal-title":"J Biol Chem"},{"issue":"2","key":"1577_CR93","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00401-018-1929-5","volume":"137","author":"S Walter","year":"2019","unstructured":"Walter S et al (2019) The metalloprotease ADAMTS4 generates N-truncated Abeta4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer\u2019s disease. Acta Neuropathol 137(2):239\u2013257","journal-title":"Acta Neuropathol"},{"issue":"5","key":"1577_CR94","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nn.3697","volume":"17","author":"T Saito","year":"2014","unstructured":"Saito T et al (2014) Single App knock-in mouse models of Alzheimer\u2019s disease. Nat Neurosci 17(5):661\u2013663","journal-title":"Nat Neurosci"},{"issue":"1","key":"1577_CR95","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/NEN.0b013e3181c6b84d","volume":"69","author":"C Guardia-Laguarta","year":"2010","unstructured":"Guardia-Laguarta C et al (2010) Clinical, neuropathologic, and biochemical profile of the amyloid precursor protein I716F mutation. J Neuropathol Exp Neurol 69(1):53\u201359","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"1577_CR96","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3233\/JAD-141524","volume":"44","author":"E Sieczkowski","year":"2015","unstructured":"Sieczkowski E et al (2015) I716F AbetaPP mutation associates with the deposition of oligomeric pyroglutamate amyloid-beta and alpha-synucleinopathy with Lewy bodies. J Alzheimers Dis 44(1):103\u2013114","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1577_CR97","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuron.2019.10.010","volume":"105","author":"F Bassil","year":"2020","unstructured":"Bassil F et al (2020) Amyloid-Beta (Abeta) plaques promote seeding and spreading of alpha-synuclein and tau in a mouse model of lewy body disorders with abeta pathology. Neuron 105(2):260-275 e6","journal-title":"Neuron"},{"issue":"2","key":"1577_CR98","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuron.2005.06.030","volume":"47","author":"E McGowan","year":"2005","unstructured":"McGowan E et al (2005) Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47(2):191\u2013199","journal-title":"Neuron"},{"key":"1577_CR99","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1749-6632.1993.tb23043.x","volume":"695","author":"JT Jarrett","year":"1993","unstructured":"Jarrett JT, Berger EP, Lansbury PT Jr (1993) The C-terminus of the beta protein is critical in amyloidogenesis. Ann N Y Acad Sci 695:144\u2013148","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"1577_CR100","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13024-018-0247-7","volume":"13","author":"L Zhong","year":"2018","unstructured":"Zhong L et al (2018) Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2). Mol Neurodegener 13(1):15","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1577_CR101","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41593-021-00951-0","volume":"25","author":"P d'Errico","year":"2022","unstructured":"d\u2019Errico P et al (2022) Microglia contribute to the propagation of Abeta into unaffected brain tissue. Nat Neurosci 25(1):20\u201325","journal-title":"Nat Neurosci"},{"key":"1577_CR102","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-022-00985-9","author":"W Cai","year":"2022","unstructured":"Cai W et al (2022) Physiological roles of beta-amyloid in regulating synaptic function: implications for AD pathophysiology. Neurosci Bull. https:\/\/doi.org\/10.1007\/s12264-022-00985-9","journal-title":"Neurosci Bull"},{"issue":"2","key":"1577_CR103","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/alzrt107","volume":"4","author":"S Weggen","year":"2012","unstructured":"Weggen S, Beher D (2012) Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer\u2019s disease. Alzheimers Res Ther 4(2):9","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"1577_CR104","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a003079","volume":"1","author":"N Giagtzoglou","year":"2009","unstructured":"Giagtzoglou N, Ly CV, Bellen HJ (2009) Cell adhesion, the backbone of the synapse: \u201cvertebrate\u201d and \u201cinvertebrate\u201d perspectives. Cold Spring Harb Perspect Biol 1(4):a003079","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"1577_CR105","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s004010050892","volume":"96","author":"P Cras","year":"1998","unstructured":"Cras P et al (1998) Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala\u2013>Gly mutation. Acta Neuropathol 96(3):253\u2013260","journal-title":"Acta Neuropathol"},{"issue":"9","key":"1577_CR106","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1212\/01.WNL.0000142965.10778.C7","volume":"63","author":"WS Brooks","year":"2004","unstructured":"Brooks WS et al (2004) Hemorrhage is uncommon in new Alzheimer family with Flemish amyloid precursor protein mutation. Neurology 63(9):1613\u20131617","journal-title":"Neurology"},{"issue":"1","key":"1577_CR107","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0006-291X(02)00430-8","volume":"294","author":"K Murakami","year":"2002","unstructured":"Murakami K et al (2002) Synthesis, aggregation, neurotoxicity, and secondary structure of various A beta 1\u201342 mutants of familial Alzheimer\u2019s disease at positions 21\u201323. Biochem Biophys Res Commun 294(1):5\u201310","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"1577_CR108","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1529\/biophysj.106.090993","volume":"91","author":"A Huet","year":"2006","unstructured":"Huet A, Derreumaux P (2006) Impact of the mutation A21G (Flemish variant) on Alzheimer\u2019s beta-amyloid dimers by molecular dynamics simulations. Biophys J 91(10):3829\u20133840","journal-title":"Biophys J"},{"issue":"35","key":"1577_CR109","doi-asserted-by":"publisher","first-page":"14745","DOI":"10.1073\/pnas.0905127106","volume":"106","author":"K Ono","year":"2009","unstructured":"Ono K, Condron MM, Teplow DB (2009) Structure-neurotoxicity relationships of amyloid beta-protein oligomers. Proc Natl Acad Sci U S A 106(35):14745\u201314750","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1577_CR110","first-page":"998","volume":"51","author":"K Kamino","year":"1992","unstructured":"Kamino K et al (1992) Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am J Hum Genet 51(5):998\u20131014","journal-title":"Am J Hum Genet"},{"issue":"10","key":"1577_CR111","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1111\/j.1460-9568.2004.03389.x","volume":"19","author":"I Klyubin","year":"2004","unstructured":"Klyubin I et al (2004) Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo. Eur J Neurosci 19(10):2839\u20132846","journal-title":"Eur J Neurosci"},{"issue":"2","key":"1577_CR112","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.neurobiolaging.2009.02.021","volume":"32","author":"A Ronnback","year":"2011","unstructured":"Ronnback A et al (2011) Progressive neuropathology and cognitive decline in a single Arctic APP transgenic mouse model. Neurobiol Aging 32(2):280\u2013292","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1577_CR113","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/j.1742-4658.2008.06836.x","volume":"276","author":"A Lord","year":"2009","unstructured":"Lord A et al (2009) Amyloid-beta protofibril levels correlate with spatial learning in Arctic Alzheimer\u2019s disease transgenic mice. FEBS J 276(4):995\u20131006","journal-title":"FEBS J"},{"issue":"14","key":"1577_CR114","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1096\/fj.03-1070fje","volume":"18","author":"K Takeda","year":"2004","unstructured":"Takeda K et al (2004) Amino-truncated amyloid beta-peptide (Abeta5-40\/42) produced from caspase-cleaved amyloid precursor protein is deposited in Alzheimer\u2019s disease brain. FASEB J 18(14):1755\u20131757","journal-title":"FASEB J"},{"issue":"17","key":"1577_CR115","doi-asserted-by":"publisher","first-page":"8142","DOI":"10.1021\/ac401055y","volume":"85","author":"U Haussmann","year":"2013","unstructured":"Haussmann U et al (2013) Analysis of amino-terminal variants of amyloid-beta peptides by capillary isoelectric focusing immunoassay. Anal Chem 85(17):8142\u20138149","journal-title":"Anal Chem"},{"issue":"2","key":"1577_CR116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031084","volume":"7","author":"N Mattsson","year":"2012","unstructured":"Mattsson N et al (2012) BACE1 inhibition induces a specific cerebrospinal fluid beta-amyloid pattern that identifies drug effects in the central nervous system. PLoS ONE 7(2):e31084","journal-title":"PLoS ONE"},{"issue":"6","key":"1577_CR117","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1212\/01.WNL.0000050140.10044.A8","volume":"60","author":"SM Greenberg","year":"2003","unstructured":"Greenberg SM et al (2003) Hemorrhagic stroke associated with the Iowa amyloid precursor protein mutation. Neurology 60(6):1020\u20131022","journal-title":"Neurology"},{"issue":"4","key":"1577_CR118","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1017\/S031716710001859X","volume":"41","author":"T Mok","year":"2014","unstructured":"Mok T et al (2014) Familial cerebral amyloid angiopathy due to the Iowa mutation in an Irish family. Can J Neurol Sci 41(4):512\u2013517","journal-title":"Can J Neurol Sci"},{"key":"1577_CR119","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1749-6632.2002.tb04824.x","volume":"977","author":"WE Van Nostrand","year":"2002","unstructured":"Van Nostrand WE et al (2002) Pathogenic effects of cerebral amyloid angiopathy mutations in the amyloid beta-protein precursor. Ann N Y Acad Sci 977:258\u2013265","journal-title":"Ann N Y Acad Sci"},{"issue":"42","key":"1577_CR120","doi-asserted-by":"publisher","first-page":"28917","DOI":"10.1074\/jbc.M109.050856","volume":"284","author":"MC Liao","year":"2009","unstructured":"Liao MC et al (2009) Degradation of amyloid beta protein by purified myelin basic protein. J Biol Chem 284(42):28917\u201328925","journal-title":"J Biol Chem"},{"key":"1577_CR121","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev-neuro-100120-122621","volume":"44","author":"KA Nave","year":"2021","unstructured":"Nave KA, Werner HB (2021) Ensheathment and myelination of axons: evolution of glial functions. Annu Rev Neurosci 44:197\u2013219","journal-title":"Annu Rev Neurosci"},{"issue":"6220","key":"1577_CR122","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen M et al (2015) Proteomics. Tissue-based map of the human proteome. Science 347(6220):1260419","journal-title":"Science"},{"issue":"3","key":"1577_CR123","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/jnr.10737","volume":"74","author":"TM Allinson","year":"2003","unstructured":"Allinson TM et al (2003) ADAMs family members as amyloid precursor protein alpha-secretases. J Neurosci Res 74(3):342\u2013352","journal-title":"J Neurosci Res"},{"key":"1577_CR124","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.nbd.2014.08.031","volume":"73","author":"TJ Oberstein","year":"2015","unstructured":"Oberstein TJ et al (2015) Astrocytes and microglia but not neurons preferentially generate N-terminally truncated Abeta peptides. Neurobiol Dis 73:24\u201335","journal-title":"Neurobiol Dis"},{"key":"1577_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105010","volume":"144","author":"SS Plotkin","year":"2020","unstructured":"Plotkin SS, Cashman NR (2020) Passive immunotherapies targeting Abeta and tau in Alzheimer\u2019s disease. Neurobiol Dis 144:105010","journal-title":"Neurobiol Dis"},{"issue":"8","key":"1577_CR126","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11910-021-01125-y","volume":"21","author":"B Decourt","year":"2021","unstructured":"Decourt B et al (2021) Critical appraisal of amyloid lowering agents in AD. Curr Neurol Neurosci Rep 21(8):39","journal-title":"Curr Neurol Neurosci Rep"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01577-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-023-01577-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-023-01577-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T04:05:08Z","timestamp":1685592308000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-023-01577-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":126,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1577"],"URL":"https:\/\/doi.org\/10.1186\/s40478-023-01577-y","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,1]]},"assertion":[{"value":"9 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"87"}}